G CHINA FIN (00431) intends to sell and Feng Limited.
China Finance (00431) announced that on February 27, 2026, the company intends to sell all issued shares of Feng Limited to Mr. Tuoguangxiong at a price of 1.00 Hong Kong dollars.
G CHINA FIN (00431) announced on February 27, 2026, that the company intends to sell all issued shares of Tou Guangxiong and Feng Limited to Mr. Tou Guangxiong for a price of 1.00 Hong Kong dollar.
It is reported that the selling company holds all the shares of nine subsidiary companies established in China through its various direct and indirect wholly-owned subsidiaries registered in the British Virgin Islands and Hong Kong (whose main business is investment holding). These subsidiaries established in China mainly engage in providing financial guarantees, loan financing, microloans, loan referrals, and consulting services in Beijing, China, and hold financing guarantee business licenses and loan financing business licenses in Beijing. However, due to the adverse impact of the Chinese economy and business environment on the selling group's business, its loan financing business in Beijing has been completely suspended, and the selling group has been non-operational since 2024.
The Board of Directors believes that the proposed sale will help alleviate the financial burden on the selling group. Considering that the selling group has recorded losses for several years and has been in a net debt position, the Board of Directors believes that the proposed sale will release capital from the group to be used for working capital in the selling group, thereby allowing resources to be allocated more efficiently to the remaining businesses of this group, namely the tobacco and fragrance business.
Related Articles

STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.
STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


